These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 28698094)

  • 1. Biomarkers of disease activity in vitiligo: A systematic review.
    Speeckaert R; Speeckaert M; De Schepper S; van Geel N
    Autoimmun Rev; 2017 Sep; 16(9):937-945. PubMed ID: 28698094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suction blistering the lesional skin of vitiligo patients reveals useful biomarkers of disease activity.
    Strassner JP; Rashighi M; Ahmed Refat M; Richmond JM; Harris JE
    J Am Acad Dermatol; 2017 May; 76(5):847-855.e5. PubMed ID: 28259440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCL-10 and Interleukin-6 are reliable serum markers for vitiligo activity: A multicenter cross-sectional study.
    Abdallah M; El-Mofty M; Anbar T; Rasheed H; Esmat S; Al-Tawdy A; Fawzy MM; Abdel-Halim D; Hegazy R; Gawdat H; Bassiouny D; Ibrahim MA; Sany I; El-Bassiouny M; Khalil M; Abdel-Aziz A; El Maadawi ZM; Mostafa WZ;
    Pigment Cell Melanoma Res; 2018 Mar; 31(2):330-336. PubMed ID: 29094481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Significance of Serum Soluble CD Molecules to Assess Disease Activity in Vitiligo.
    Speeckaert R; Lambert J; van Geel N
    JAMA Dermatol; 2016 Nov; 152(11):1194-1200. PubMed ID: 27556155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A meta-analysis of chemokines in vitiligo: Recruiting immune cells towards melanocytes.
    Speeckaert R; Belpaire A; Speeckaert MM; van Geel N
    Front Immunol; 2023; 14():1112811. PubMed ID: 36911664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A similar local immune and oxidative stress phenotype in vitiligo and halo nevus.
    Yang Y; Li S; Zhu G; Zhang Q; Wang G; Gao T; Li C; Wang L; Jian Z
    J Dermatol Sci; 2017 Jul; 87(1):50-59. PubMed ID: 28385330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keratinocyte-Derived Chemokines Orchestrate T-Cell Positioning in the Epidermis during Vitiligo and May Serve as Biomarkers of Disease.
    Richmond JM; Bangari DS; Essien KI; Currimbhoy SD; Groom JR; Pandya AG; Youd ME; Luster AD; Harris JE
    J Invest Dermatol; 2017 Feb; 137(2):350-358. PubMed ID: 27686391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin Interstitial Fluid and Plasma Multiplex Cytokine Analysis Reveals IFN-γ Signatures and Granzyme B as Useful Biomarker for Activity, Severity and Prognosis Assessment in Vitiligo.
    Ng CY; Chiu YC; Chan YP; Lin YJ; Chung PH; Chung WH; Ku CL
    Front Immunol; 2022; 13():872458. PubMed ID: 35464413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress drives CD8
    Li S; Zhu G; Yang Y; Jian Z; Guo S; Dai W; Shi Q; Ge R; Ma J; Liu L; Li K; Luan Q; Wang G; Gao T; Li C
    J Allergy Clin Immunol; 2017 Jul; 140(1):177-189.e9. PubMed ID: 27826097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of CXCR3 and its ligands in patients with vitiligo and CXCL10 as a potential clinical marker for vitiligo.
    Wang XX; Wang QQ; Wu JQ; Jiang M; Chen L; Zhang CF; Xiang LH
    Br J Dermatol; 2016 Jun; 174(6):1318-26. PubMed ID: 26801009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First histopathological and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo nevi.
    van Geel NA; Mollet IG; De Schepper S; Tjin EP; Vermaelen K; Clark RA; Kupper TS; Luiten RM; Lambert J
    Pigment Cell Melanoma Res; 2010 Jun; 23(3):375-84. PubMed ID: 20370855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of FOXO3A gene polymorphisms with serum FOXO3A levels and oxidative stress markers in vitiligo patients.
    Ozel Turkcu U; Solak Tekin N; Gokdogan Edgunlu T; Karakas Celik S; Oner S
    Gene; 2014 Feb; 536(1):129-34. PubMed ID: 24333267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of CXCL12 in Serum of Patients with Vitiligo.
    Speeckaert R; Ongenae K; van Geel N
    J Invest Dermatol; 2017 Jul; 137(7):1586-1588. PubMed ID: 28238843
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased systemic and epidermal levels of IL-17A and IL-1β promotes progression of non-segmental vitiligo.
    Bhardwaj S; Rani S; Srivastava N; Kumar R; Parsad D
    Cytokine; 2017 Mar; 91():153-161. PubMed ID: 28082234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating CXCL10 is increased in non-segmental vitiligo, in presence or absence of autoimmune thyroiditis.
    Ferrari SM; Fallahi P; Santaguida G; Virili C; Ruffilli I; Ragusa F; Centanni M; Antonelli A
    Autoimmun Rev; 2017 Sep; 16(9):946-950. PubMed ID: 28698095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL12 as a Predictor of Vitiligo Activity and Disease Progression.
    Alexeev V
    J Invest Dermatol; 2017 Jul; 137(7):1588-1590. PubMed ID: 28365260
    [No Abstract]   [Full Text] [Related]  

  • 17. Dysregulation of melanocyte function by Th17-related cytokines: significance of Th17 cell infiltration in autoimmune vitiligo vulgaris.
    Kotobuki Y; Tanemura A; Yang L; Itoi S; Wataya-Kaneda M; Murota H; Fujimoto M; Serada S; Naka T; Katayama I
    Pigment Cell Melanoma Res; 2012 Mar; 25(2):219-30. PubMed ID: 22136309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced Th1 and Th17 responses in peripheral blood in active non-segmental vitiligo.
    Zhen Y; Yao L; Zhong S; Song Y; Cui Y; Li S
    Arch Dermatol Res; 2016 Dec; 308(10):703-710. PubMed ID: 27687555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type I interferon signature in the initiation of the immune response in vitiligo.
    Bertolotti A; Boniface K; Vergier B; Mossalayi D; Taieb A; Ezzedine K; Seneschal J
    Pigment Cell Melanoma Res; 2014 May; 27(3):398-407. PubMed ID: 24438589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of oxidative damage and proinflammatory cytokines are enhanced in patients with active vitiligo.
    Mitra S; De Sarkar S; Pradhan A; Pati AK; Pradhan R; Mondal D; Sen S; Ghosh A; Chatterjee S; Chatterjee M
    Free Radic Res; 2017 Dec; 51(11-12):986-994. PubMed ID: 29182456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.